MD2872G2 - Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare - Google Patents

Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare

Info

Publication number
MD2872G2
MD2872G2 MDA20050062A MD20050062A MD2872G2 MD 2872 G2 MD2872 G2 MD 2872G2 MD A20050062 A MDA20050062 A MD A20050062A MD 20050062 A MD20050062 A MD 20050062A MD 2872 G2 MD2872 G2 MD 2872G2
Authority
MD
Moldova
Prior art keywords
risk
hyperplasia
appearance
dyshormonal
mammary
Prior art date
Application number
MDA20050062A
Other languages
English (en)
Russian (ru)
Other versions
MD2872F1 (ro
Inventor
Михаил СУРГУЧ
Original Assignee
Михаил СУРГУЧ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Михаил СУРГУЧ filed Critical Михаил СУРГУЧ
Priority to MDA20050062A priority Critical patent/MD2872G2/ro
Publication of MD2872F1 publication Critical patent/MD2872F1/ro
Publication of MD2872G2 publication Critical patent/MD2872G2/ro

Links

Abstract

Invenţia se referă la medicină, în special la ginecologie şi poate fi utilizată pentru pronosticarea riscului apariţiei hiperplaziei dishormonale a glandei mamare la pacientele cu maladii ginecologice şi neginecologice asociate.Esenţa invenţiei constă în aceea că se recoltează sânge de la pacientă, se separă plasma sanguină, se determină concentraţia enterolactonei în ea şi, dacă aceasta este de 13…30 nmol/L, se prognozează un risc major de apariţie a hiperplaziei dishormonale, dacă de 30…70 nmol/L un risc mediu şi 70…118 nmol/L un risc minor de apariţie a hiperplaziei dishormonale a glandei mamare.
MDA20050062A 2005-03-04 2005-03-04 Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare MD2872G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050062A MD2872G2 (ro) 2005-03-04 2005-03-04 Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050062A MD2872G2 (ro) 2005-03-04 2005-03-04 Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare

Publications (2)

Publication Number Publication Date
MD2872F1 MD2872F1 (ro) 2005-10-31
MD2872G2 true MD2872G2 (ro) 2006-05-31

Family

ID=35229985

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050062A MD2872G2 (ro) 2005-03-04 2005-03-04 Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare

Country Status (1)

Country Link
MD (1) MD2872G2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1119Z (ro) * 2016-05-06 2017-09-30 Оксана ОДОБЕСКУ Metodă de pronosticare a riscului de malignizare a tumorii filoide a glandei mamare

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD890Z (ro) * 2014-05-30 2015-10-31 Симона КЯБУРУ Metodă de pronostic al riscului dezvoltării hiperplaziei dishormonale a glandei mamare

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Pietinen P., Stumpf K., et al. Serum enterolactone and risk of breast cancer, A case-control study in eastern Finland. Cancer Epidemiology, Bomarkers& Prevention, 2001, p. 10, 339-344 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD1119Z (ro) * 2016-05-06 2017-09-30 Оксана ОДОБЕСКУ Metodă de pronosticare a riscului de malignizare a tumorii filoide a glandei mamare

Also Published As

Publication number Publication date
MD2872F1 (ro) 2005-10-31

Similar Documents

Publication Publication Date Title
IL291162A (en) Isolated human rpe cells and their use for the treatment of retinal degenerative diseases
HK1069316A1 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
ES2249490T3 (es) Articulos quirurgicos.
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
NO20044039L (no) Konjugatorer av terapeutiske eller cytotoksiske midler og biologisk aktive peptider.
ATE432677T1 (de) Gerät zur ablage von geflochtenen prothesen
WO2005097219A3 (en) Ecm-based graft material
ATE539701T1 (de) Zusammengesetzte schlinge zur behandlung von inkontinenz
WO2008045228A3 (en) Medical devices having porous regions for controlled therapeutic agent exposure or delivery
TW200505881A (en) Tri(cyclo) substituted amide compounds
SG171648A1 (en) Use of dpp-iv inhibitors
SG10201503235VA (en) Inhibitors Of Bruton`s Tyrosine Kinase
HK1096392A1 (en) Substituted heterocycles
HK1109070A1 (en) Treatment articles capable of conforming to an underlying shape
WO2005043967A8 (en) Z-axis assembly of medical device programmer
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
TW200642682A (en) A combination of medical drugs to augment the anti-cancer effect of chemotherapy
WO2005072277A3 (en) Amidated parathyroid hormone fragments and uses thereof
WO2006027693A3 (en) Tumor specific genes and variant RNAS and uses thereof as targets for cancer therapy and diagnosis
WO2004031129A3 (en) Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
NO20053903L (no) Nukleotidlipidesterderivater.
PL1869185T3 (pl) Koniugat zawierający białko P21 do leczenia raka
MD2872G2 (ro) Metodă de pronostic al riscului apariţiei hiperplaziei dishormonale a glandei mamare
WO2007118077A3 (en) Mycobacterial catalase-peroxidase in the diagnosis and treatment of sarcoidosis
EP1370697A4 (en) PEROXYREDOXIN-BASED MEDICINAL PRODUCTS FOR THE TREATMENT OF HIV-1 INFECTIONS AND METHODS OF USE

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees